MedPath

Fatty Acid Quality and Overweight (FO-study)

Not Applicable
Completed
Conditions
Weight Reduction and Insulin Sensitivity
Interventions
Dietary Supplement: fatty acid quality and overweight
Registration Number
NCT01034436
Lead Sponsor
Oslo Metropolitan University
Brief Summary

The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • no use of medication, healthy, 27<BMI<40
Exclusion Criteria
  • pregnant and lactating women, chronic diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low intake of ALA and triacylglycerolsfatty acid quality and overweightSunflower oil
high intake of ALA and triacylglycerolesfatty acid quality and overweightCanola and linseed oils
high intake of ALA and diacylglycerolsfatty acid quality and overweightCanola and linseed oils
Primary Outcome Measures
NameTimeMethod
Will intake of fat as diacylglycerols give weight reduction in overweight individuals?baseline (0 weeks), 12 weeks
Secondary Outcome Measures
NameTimeMethod
Will a high intake of ALA involve reduced levels of inflammatory markers?baseline (0 weeks), 12 weeks
Will a high intake of ALA involve changes in insulin sensitivity?baseline (0 weeks), 12 weeks

Trial Locations

Locations (1)

Akershus University College

🇳🇴

Oslo, Lillestrom, Norway

© Copyright 2025. All Rights Reserved by MedPath